Morgan Stanley Cabaletta Bio, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 828,829 shares of CABA stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

828,829

Previous 295,509 180.48%

Holding current value

$1.86 Million

Previous $2.21 Million 77.01%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.94 - $8.24 $2.1 Million - $4.39 Million	533,320 Added 180.48%	828,829 $3.91 Million
Q2 2024 Oct 17, 2024	SELL	$7.22 - $18.82 $4.26 Million - $11.1 Million	-590,195 Reduced 66.64%	295,509 $2.21 Million
Q2 2024 Aug 14, 2024	SELL	$7.22 - $18.82 $4.26 Million - $11.1 Million	-590,195 Reduced 66.64%	295,509 $2.21 Million
Q1 2024 Oct 17, 2024	BUY	$16.79 - $25.38 $9.91 Million - $15 Million	590,195 Added 199.72%	885,704 $15.1 Million
Q1 2024 Aug 16, 2024	BUY	$16.79 - $25.38 $8.37 Million - $12.6 Million	498,321 Added 128.64%	885,704 $15.1 Million
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $8.37 Million - $12.6 Million	498,321 Added 128.64%	885,704 $15.1 Million
Q4 2023 Aug 16, 2024	BUY	$12.21 - $23.36 $1.12 Million - $2.15 Million	91,874 Added 31.09%	387,383 $8.79 Million
Q4 2023 Feb 13, 2024	BUY	$12.21 - $23.36 $2.02 Million - $3.86 Million	165,366 Added 74.48%	387,383 $8.79 Million
Q3 2023 Nov 15, 2023	BUY	$11.84 - $18.65 $173,527 - $273,334	14,656 Added 7.07%	222,017 $3.38 Million
Q2 2023 Aug 14, 2023	BUY	$7.65 - $13.95 $38,288 - $69,819	5,005 Added 2.47%	207,361 $2.68 Million
Q1 2023 May 15, 2023	BUY	$7.08 - $12.62 $15,583 - $27,776	2,201 Added 1.1%	202,356 $1.67 Million
Q4 2022 Feb 14, 2023	BUY	$0.64 - $9.3 $19,670 - $285,835	30,735 Added 18.14%	200,155 $1.85 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $2.05 $29,937 - $97,415	47,520 Added 38.98%	169,420 $110,000
Q2 2022 Oct 27, 2022	BUY	$0.99 - $2.11 $21,782 - $46,426	22,003 Added 22.03%	121,900 $129,000
Q2 2022 Aug 15, 2022	BUY	$0.99 - $2.11 $21,782 - $46,426	22,003 Added 22.03%	121,900 $129,000
Q1 2022 Oct 27, 2022	SELL	$1.68 - $3.92 $36,965 - $86,251	-22,003 Reduced 18.05%	99,897 $203,000
Q1 2022 May 13, 2022	BUY	$1.68 - $3.92 $82,867 - $193,357	49,326 Added 97.54%	99,897 $203,000
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $98,605 - $429,640	-29,347 Reduced 36.72%	50,571 $191,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $559,426 - $998,975	79,918 New	79,918 $972,000

Others Institutions Holding CABA

# of Institutions

126

Shares Held

47.9M

Call Options Held

202K

Put Options Held

110K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $65.3M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account